Achievement of Goals in U.S. Diabetes Care, 1999–2010
Open accessThe DOI matches its Crossref record; 40 of the 40 references it cites were found in a registry or an index.
Abstract
BACKGROUND: Tracking national progress in diabetes care may aid in the evaluation of past efforts and identify residual gaps in care. METHODS: We analyzed data for adults with self-reported diabetes from the National Health and Nutrition Examination Survey and the Behavioral Risk Factor Surveillance System to examine risk-factor control, preventive practices, and risk scores for coronary heart disease over the 1999-2010 period. RESULTS: From 1999 through 2010, the weighted proportion of survey participants who met recommended goals for diabetes care increased, by 7.9 percentage points (95% confidence interval [CI], 0.8 to 15.0) for glycemic control (glycated hemoglobin level <7.0%), 9.4 percentage points (95% CI, 3.0 to 15.8) for individualized glycemic targets, 11.7 percentage points (95% CI, 5.7 to 17.7) for blood pressure (target, <130/80 mm Hg), and 20.8 percentage points (95% CI, 11.6 to 30.0) for lipid levels (target level of low-density lipoprotein [LDL] cholesterol, <100 mg per deciliter [2.6 mmol per liter]). Tobacco use did not change significantly, but the 10-year probability of coronary heart disease decreased by 2.8 to 3.7 percentage points. However, 33.4 to 48.7% of persons with diabetes still did not meet the targets for glycemic control, blood pressure, or LDL cholesterol level. Only 14.3% met the targets for all three of these measures and for tobacco use. Adherence to the recommendations for annual eye and dental examinations was unchanged, but annual lipid-level measurement and foot examination increased by 5.5 percentage points (95% CI, 1.6 to 9.4) and 6.8 percentage points (95% CI, 4.8 to 8.8), respectively. Annual vaccination for influenza and receipt of pneumococcal vaccination for participants 65 years of age or older rose by 4.5 percentage points (95% CI, 0.8 to 8.2) and 6.9 percentage points (95% CI, 3.4 to 10.4), respectively, and daily glucose monitoring increased by 12.7 percentage points (95% CI, 10.3 to 15.1). CONCLUSIONS: Although there were improvements in risk-factor control and adherence to preventive practices from 1999 to 2010, tobacco use remained high, and almost half of U.S. adults with diabetes did not meet the recommended goals for diabetes care.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Still, many do not meet the recommended goals for diabetes care [7-9]; in Norway, research has shown that only 20% attain the target for metabolic control for glycated hemoglobin A1c (HbA1c), blood pressure, and lipid level, although the quality of care has improved [8].”
In the citing paper
“there is evidence that measures of 10-year CHD risk among U.S. adults with diabetes have improved signi fi cantly over the past decade (2)”
From 10. Cardiovascular Disease and Risk Management: Standards of Care in Diabetes—2023 (2023) · cites this paper as [2]
Citations
Cites
(1993) · New England Journal of Medicine · doi:10.1056/nejm199309303291401 · Cited by 24,667
Prediction of coronary heart disease using risk factor categories
Wilson, P. W. F., D’Agostino, R. B., Levy, D., Belanger, A. M., Silbershatz, H., & Kannel, W. B. (1998) · Circulation · doi:10.1161/01.cir.97.18.1837 · Cited by 9,581
Effects of Intensive Glucose Lowering in Type 2 Diabetes
(2008) · New England Journal of Medicine · doi:10.1056/nejmoa0802743 · Cited by 7,888
10-year follow-up of intensive glucose control in type 2 diabetes
Holman, R. R., Paul, S. K., Bethel, M. A., Matthews, D. R., & Neil, H. A. W. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa0806470 · Cited by 7,751
Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes
(2008) · New England Journal of Medicine · doi:10.1056/nejmoa0802987 · Cited by 7,397
No adjustments are needed for multiple comparisons.
Rothman, K. J. (1990) · Epidemiology · doi:10.1097/00001648-199001000-00010 · Cited by 5,965
Intensive diabetes treatment and cardiovascular disease in patients with type 1 diabetes
(2005) · New England Journal of Medicine · doi:10.1056/nejmoa052187 · Cited by 5,138
Glucose control and vascular complications in veterans with type 2 diabetes
Duckworth, W., Abraira, C., Moritz, T., Reda, D., Emanuele, N., Reaven, P. D., Zieve, F. J., Marks, J., Davis, S. N., Hayward, R., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0808431 · Cited by 4,762
Research works printed but not linked: 2
- Ahmann AJ, 2007, Am J Manag Care, 13, S41
- Gary TL, 2003, Ethn Dis, 13, 47
Cited by
Items 101–200 of 978
Trends in food insecurity for adults with cardiometabolic disease in the United States: 2005-2012
Berkowitz, S. A., Berkowitz, T. S. Z., Meigs, J. B., & Wexler, D. J. (2017) · PLOS ONE · doi:10.1371/journal.pone.0179172 · Cited by 141
Bergenstal, R. M. (2015) · Diabetes Care · doi:10.2337/dc15-0099 · Cited by 140
“2% from 1999–2002 to 2007– 2010, respectively) (25).”
Uric Acid as a Biomarker and a Therapeutic Target in Diabetes
Lytvyn, Y., Perkins, B. A., & Cherney, D. Z. I. (2015) · Canadian Journal of Diabetes · doi:10.1016/j.jcjd.2014.10.013 · Cited by 152
Simonson, D. C., Halperin, F., Foster, K., Vernon, A., & Goldfine, A. B. (2018) · Diabetes Care · doi:10.2337/dc17-0487 · Cited by 136
Optimal prandial timing of bolus insulin in diabetes management: a review
Slattery, D., Amiel, S. A., & Choudhary, P. (2018) · Diabetic Medicine · doi:10.1111/dme.13525 · Cited by 132
“[4].”
Pantalone, K. M., Hobbs, T. M., Wells, B. J., Kong, S. X., Kattan, M. W., Bouchard, J., Yu, C., Sakurada, B., Milinovich, A., Weng, W., et al. (2015) · BMJ Open Diabetes Research & Care · doi:10.1136/bmjdrc-2015-000093 · Cited by 134
“While reports have suggested that we continue to make progress in attaining glycemic targets and managing comorbidities, in addition to reducing the rates of diabetes-related complications, there is still substantial room for improvement.(6) 7 Over the past few decades, integrated health delivery systems have evolved,…”
BackgroundPeripheral neuropathy and the risk of cardiovascular events in type 2 diabetes mellitus
Brownrigg, J. R. W., de Lusignan, S., McGovern, A., Hughes, C., Thompson, M. M., Ray, K. K., & Hinchliffe, R. J. (2014) · Heart · doi:10.1136/heartjnl-2014-305657 · Cited by 130
Nauck, M. A., Stewart, M. W., Perkins, C., Jones-Leone, A., Yang, F., Perry, C., Reinhardt, R. R., & Rendell, M. (2016) · Diabetologia · doi:10.1007/s00125-015-3795-1 · Cited by 125
“00 mmol/mol) [3] and, while a systematic review showed there to be variability with regard to attainment of an HbA1c goal of <7% (53.”
BackgroundCardiovascular Diseases in India Compared With the United States
Prabhakaran, D., Singh, K., Roth, G. A., Banerjee, A., Pagidipati, N. J., & Huffman, M. D. (2018) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2018.04.042 · Cited by 133
“National Health and Nutrition Examination Survey found that 52% of individuals with diabetes achieved glycosylated hemoglobin levels <7% between 2007 and 2010 (45).”
BackgroundNichols, G. A., Philip, S., Reynolds, K., Granowitz, C. B., & Fazio, S. (2019) · Diabetes, Obesity and Metabolism · doi:10.1111/dom.13537 · Cited by 125
Aschner, P., Gagliardino, J. J., Ilkova, H., Lavalle, F., Ramachandran, A., Mbanya, J. C., Shestakova, M., Chantelot, J.-M., & Chan, J. C. N. (2020) · Diabetologia · doi:10.1007/s00125-019-05078-3 · Cited by 120
Luk, A. O. Y., Lau, E. S. H., So, W.-Y., Ma, R. C. W., Kong, A. P. S., Ozaki, R., Chow, F. C. C., & Chan, J. C. N. (2014) · Diabetes Care · doi:10.2337/dc13-1336 · Cited by 121
“(28), not only were young patients less able to reach treatment targets compared with older adults but the rates of target attainment in the young group have not changed over the past decade.”
BackgroundClinical inertia—time to reappraise the terminology?
Khunti, K., & Davies, M. J. (2017) · Primary Care Diabetes · doi:10.1016/j.pcd.2017.01.007 · Cited by 121
“Inertia is also evident for prevention strategies with many patients with diabetes not having the recommended vaccinations or smoking cessation [8].”
Background1. Promoting Health and Reducing Disparities in Populations
American Diabetes Association (2017) · Diabetes Care · doi:10.2337/dc17-s004 · Cited by 119
“Nevertheless, 33–49% of patients still do not meet targets for glycemic, blood pressure, or cholesterol control, and only 14% meet targets for all three measures while also avoiding smoking (2).”
BackgroundInfluentialWang, Y., & Sloan, F. A. (2018) · Journal of Risk and Uncertainty · doi:10.1007/s11166-018-9289-z · Cited by 129
Cardiometabolic-Based Chronic Disease, Addressing Knowledge and Clinical Practice Gaps
Mechanick, J. I., Farkouh, M. E., Newman, J. D., & Garvey, W. T. (2020) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2019.11.046 · Cited by 113
Ding, S.-A., Simonson, D. C., Wewalka, M., Halperin, F., Foster, K., Goebel-Fabbri, A., Hamdy, O., Clancy, K., Lautz, D., Vernon, A., et al. (2015) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2015-1443 · Cited by 113
“After randomization, five participants did not undergo surgery (four participants withdrew consent, one was found to have severe aortic dilatation) and are not included further in summary data 2548 Ding et al Surgery or Lifestyle and Medical Management in T2D J Clin Endocrinol Metab, July 2015, 100(7):2546–2556”
InfluentialPatient-Driven Diabetes Care of the Future in the Technology Era
Ashrafzadeh, S., & Hamdy, O. (2019) · Cell Metabolism · doi:10.1016/j.cmet.2018.09.005 · Cited by 111
Trends in Insulin Use and Diabetes Control in the U.S.: 1988–1994 and 1999–2012
Selvin, E., Parrinello, C. M., Daya, N., & Bergenstal, R. M. (2016) · Diabetes Care · doi:10.2337/dc15-2229 · Cited by 110
Ali, M. K., Singh, K., Kondal, D., Devarajan, R., Patel, S. A., Shivashankar, R., Ajay, V. S., Unnikrishnan, A. G., Menon, V. U., Varthakavi, P. K., et al. (2016) · Annals of Internal Medicine · doi:10.7326/m15-2807 · Cited by 109
“Gregg EW, Li Y, Wang J, Burrows NR, Ali MK, Rolka D, et al. Changes in diabetes-related complications in the United States, 1990–2010.”
BackgroundInfluentialSelf-citationBukhsh, A., Khan, T. M., Nawaz, M. S., Ahmed, H. S., Chan, K., & Goh, B. H. (2019) · Diabetes Metabolic Syndrome and Obesity · doi:10.2147/dmso.s209711 · Cited by 108
1. Strategies for Improving Care
American Diabetes Association (2015) · Diabetes Care · doi:10.2337/dc16-s004 · Cited by 148
“Evidence also suggests that progress in cardiovascular risk factor control (particularly tobacco use) may be slowing (2,3).”
BackgroundInfluentialBarriers to Eye Care Among People Aged 40 Years and Older With Diagnosed Diabetes, 2006–2010
Chou, C.-F., Sherrod, C. E., Zhang, X., Barker, L. E., Bullard, K. M., Crews, J. E., & Saaddine, J. B. (2014) · Diabetes Care · doi:10.2337/dc13-1507 · Cited by 109
Self-citationLiu, X., Li, Y., Li, L., Zhang, L., Ren, Y., Zhou, H., Cui, L., Mao, Z., Hu, D., & Wang, C. (2016) · Scientific Reports · doi:10.1038/srep31426 · Cited by 122
“Epidemiological studies have confirmed that T2DM prevention and control were crucial to postpone or decrease its incidence related complications and its financial burden 14 .”
Ahmann, A., Rodbard, H. W., Rosenstock, J., Lahtela, J. T., de Loredo, L., Tornøe, K., Boopalan, A., Nauck, M. A., & on behalf of the NN2211‐3917 Study Group (2015) · Diabetes, Obesity and Metabolism · doi:10.1111/dom.12539 · Cited by 104
“Achieving and maintaining individualized glycaemic targets, minimizing the risk of hypoglycaemia and preventing complications present challenges in the management type 2 diabetes [1].”
BackgroundWe Can Change the Natural History of Type 2 Diabetes
Phillips, L. S., Ratner, R. E., Buse, J. B., & Kahn, S. E. (2014) · Diabetes Care · doi:10.2337/dc14-0817 · Cited by 103
1. Improving Care and Promoting Health in Populations: Standards of Medical Care in Diabetes—2018
American Diabetes Association (2018) · Diabetes Care · doi:10.2337/dc18-s001 · Cited by 95
“Evidence suggests that progress in cardiovascular risk factor control (particularly tobacco use) may be slowing (3,4).”
BackgroundInfluentialFranz, M., Boucher, J. L., & Evert, A. B. (2014) · Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy · doi:10.2147/dmso.s45140 · Cited by 97
“Unfortunately, national data in the US indicate that only about a half of persons with diabetes receive diabetes education and even fewer see a registered dietitian/nutritionist.(9) One study of over 18,000 people with diabetes revealed that only 9.”
BackgroundSustained Use of Patient Portal Features and Improvements in Diabetes Physiological Measures
Shimada, S. L., Allison, J. J., Rosen, A. K., Feng, H., & Houston, T. K. (2016) · Journal of Medical Internet Research · doi:10.2196/jmir.5663 · Cited by 97
Luk, A. O. Y., Hui, E. M. T., Sin, M.-C., Yeung, C.-Y., Chow, W.-S., Ho, A. Y. Y., Hung, H.-F., Kan, E., Ng, C.-M., So, W.-Y., et al. (2017) · Diabetes Care · doi:10.2337/dc16-2354 · Cited by 98
“, the respective figures were 52, 51, and 57%, among patients assessed between 2007 and 2010 (17).”
BackgroundGembillo, G., Ingrasciotta, Y., Crisafulli, S., Luxi, N., Siligato, R., Santoro, D., & Trifirò, G. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22094824 · Cited by 113
“8% in those without DM, and patients with depression are more likely to have concerns related to starting the treatment with insulin [105,116].”
Yan, Y., Sha, Y., Yao, G., Wang, S., Kong, F., Liu, H., Zhang, G., Zhang, H., Hu, C., & Zhang, X. (2016) · Medicine · doi:10.1097/md.0000000000003462 · Cited by 94
“However, few patients manage to satisfy the targets of T2DM treatment concepts.(10) Although originally developed solely as a weight loss therapy, it has been shown that bariatric surgery not only leads to substantial weight loss but also to T2DM remission for patients with severe obesity.”
BackgroundGlobal variation in diabetes diagnosis and prevalence based on fasting glucose and hemoglobin A1c
NCD Risk Factor Collaboration (NCD-RisC), Zhou, B., Sheffer, K. E., Bennett, J. E., Gregg, E. W., Danaei, G., Singleton, R. K., Shaw, J. E., Mishra, A., Lhoste, V. P. F., et al. (2023) · Nature Medicine · doi:10.1038/s41591-023-02610-2 · Cited by 94
“…to define the diagnostic cutoff points were all based on single measurements of glycemia 8,56 , as are epidemiological and surveillance studies 44,57–59 , many clinical guidelines recommend using a second confirmatory test for diabetes diagnosis and initiating treatment 10–13 (we note that there…”
Self-citationThe Changing Landscape of Diabetes Therapy for Cardiovascular Risk Reduction
Newman, J. D., Vani, A. K., Aleman, J. O., Weintraub, H. S., Berger, J. S., & Schwartzbard, A. Z. (2018) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2018.07.071 · Cited by 93
“Overall, background medical therapy for CVD prevention in these trials was similar to or exceeds that seen in current clinical practice (4).”
Miller, S., Krumins, T., Zhou, H., Huyck, S., Johnson, J., Golm, G., Terra, S. G., Mancuso, J. P., Engel, S. S., & Lauring, B. (2018) · Diabetes Therapy · doi:10.1007/s13300-017-0358-0 · Cited by 87
Gamboa, C. M., Colantonio, L. D., Brown, T. M., Carson, A. P., & Safford, M. M. (2017) · Journal of the American Heart Association · doi:10.1161/jaha.116.004264 · Cited by 89
“medication(12) and suboptimal LDL-C control in persons with diabetes mellitus.(7,13) Lower statin use by blacks and women has been observed in general primary-care populations,(14-19) but no studies have examined patterns of statin use by race-sex groups among individuals with diabetes mellitus in the United States.”
BackgroundResultClinical inertia, reverse clinical inertia, and medication non-adherence in type 2 diabetes
Giugliano, D., Maiorino, M. I., Bellastella, G., & Esposito, K. (2018) · Journal of Endocrinological Investigation · doi:10.1007/s40618-018-0951-8 · Cited by 99
Achievement of Goals in U.S. Diabetes Care, 1999–2010
Ali, M. K., Bullard, K. M., & Gregg, E. W. (2013) · New England Journal of Medicine · doi:10.1056/nejmc1306652 · Cited by 94
Matthaei, S., Catrinoiu, D., Celiñski, A., Ekholm, E., Cook, W., Hirshberg, B., Chen, H., Iqbal, N., & Hansen, L. (2015) · Diabetes Care · doi:10.2337/dc15-0811 · Cited by 91
Type 2 Diabetes: Why We Are Winning the Battle but Losing the War? 2015 Kelly West Award Lecture
Narayan, K. M. V. (2016) · Diabetes Care · doi:10.2337/dc16-0205 · Cited by 84
“For example, suchdocumentationhas revealed that control of vascular risk factors, HbA1c, bloodpressure, and LDL cholesterol among peoplewith diabetes have all improved in the period 1999–2000 (17).”
BackgroundThe War on Diabetic Retinopathy: Where Are We Now?
Wong, T. Y., & Sabanayagam, C. (2019) · Asia-Pacific Journal of Ophthalmology · doi:10.1097/apo.0000000000000267 · Cited by 84
Castellana, M., Cignarelli, A., Brescia, F., Laviola, L., & Giorgino, F. (2019) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.3082 · Cited by 84
O'Neil, P. M., Miller‐Kovach, K., Tuerk, P. W., Becker, L. E., Wadden, T. A., Fujioka, K., Hollander, P. L., Kushner, R. F., Timothy Garvey, W., Rubino, D. M., et al. (2016) · Obesity · doi:10.1002/oby.21616 · Cited by 85
“6% of respondents with diabetes reported receiving any diabetes education at diagnosis (26).”
BackgroundGilbert, T. R., Noar, A., Blalock, O., & Polonsky, W. H. (2021) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2020.0666 · Cited by 81
Yokoyama, H., Oishi, M., Takamura, H., Yamasaki, K., Shirabe, S.-I., Uchida, D., Sugimoto, H., Kurihara, Y., Araki, S.-I., & Maegawa, H. (2016) · BMJ Open Diabetes Research & Care · doi:10.1136/bmjdrc-2016-000294 · Cited by 85
“The proportions that met the treatment targets in this study are similar to those reported among 1444 subjects with adult diabetes from the National Health and Nutrition Examination Survey (NHANES) data surveyed in 2010.(9) The findings showed 52.”
ResultAnjana, R. M., Unnikrishnan, R., Deepa, M., Venkatesan, U., Pradeepa, R., Joshi, S., Saboo, B., Das, A. K., Bajaj, S., Bhansali, A., et al. (2022) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(22)00072-9 · Cited by 88
Self-citation1. Strategies for Improving Care
American Diabetes Association (2015) · Diabetes Care · doi:10.2337/dc15-s004 · Cited by 80
Harding, J. L., Andes, L. J., Rolka, D. B., Imperatore, G., Gregg, E. W., Li, Y., & Albright, A. (2020) · Diabetes Care · doi:10.2337/dc20-0586 · Cited by 73
Self-citationZhou, H., Zhu, J., Liu, L., Fan, L., Fish, A. F., Chen, T., & Lou, Q. (2017) · Psychiatry Research · doi:10.1016/j.psychres.2017.02.049 · Cited by 86
Harding, J. L., Weber, M. B., & Shaw, J. E. (2024) · Wiley eBooks · doi:10.1002/9781119697473.ch3 · Cited by 103
Kulzer, B., Daenschel, W., Daenschel, I., Schramm, W., Messinger, D., Weissmann, J., Vesper, I., Parkin, C. G., & Heinemann, L. (2018) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2018.09.002 · Cited by 77
Harding, J. L., Benoit, S. R., Gregg, E. W., Pavkov, M. E., & Perreault, L. (2020) · Diabetes Care · doi:10.2337/dc19-0653 · Cited by 73
“Third, there may be a stagnation in preventive care, evidenced by a decline in theproportion of young adults with diabetes meeting individualized HbA1c targets (34,35).”
BackgroundSelf-citationJacobs-Wingo, J. L., Espey, D. K., Groom, A. V., Phillips, L. E., & Haverkamp, D. S. (2016) · American Journal of Public Health · doi:10.2105/ajph.2015.303033 · Cited by 78
Benson, G. A., Sidebottom, A., Hayes, J., Miedema, M. D., Boucher, J., Vacquier, M., Sillah, A., Gamam, S., & VanWormer, J. J. (2019) · Journal of the Academy of Nutrition and Dietetics · doi:10.1016/j.jand.2018.11.013 · Cited by 74
on Behalf of the Taskforce Team of Diabetes Fact Sheet of the Korean Diabetes Association, Jung, C. H., Chung, J. O., Han, K., Ko, S.-H., Ko, K. S., & Park, J.-Y. (2017) · Cardiovascular Diabetology · doi:10.1186/s12933-016-0482-6 · Cited by 74
Change in Medical Spending Attributable to Diabetes: National Data From 1987 to 2011
Zhuo, X., Zhang, P., Kahn, H. S., Bardenheier, B. H., Li, R., & Gregg, E. W. (2015) · Diabetes Care · doi:10.2337/dc14-1687 · Cited by 73
Self-citationNew research directions on disparities in obesity and type 2 diabetes
Thornton, P. L., Kumanyika, S. K., Gregg, E. W., Araneta, M. R., Baskin, M. L., Chin, M. H., Crespo, C. J., de Groot, M., Garcia, D. O., Haire‐Joshu, D., et al. (2020) · Annals of the New York Academy of Sciences · doi:10.1111/nyas.14270 · Cited by 73
Self-citationMaterial Need Support Interventions for Diabetes Prevention and Control: a Systematic Review
Barnard, L. S., Wexler, D. J., DeWalt, D. A., & Berkowitz, S. A. (2015) · Current Diabetes Reports · doi:10.1007/s11892-014-0574-1 · Cited by 80
Neumiller, J. J. (2014) · Drugs in Context · doi:10.7573/dic.212262 · Cited by 91
The Landscape of Diabetic Kidney Disease in the United States
Duru, O. K., Middleton, T. R., Tewari, M. K., & Norris, K. C. (2018) · Current Diabetes Reports · doi:10.1007/s11892-018-0980-x · Cited by 81
Fatores associados ao controle glicêmico de pessoas com diabetes mellitus
Rossaneis, M. Â., de Andrade, S. M., Gvozd, R., Pissinati, P. D. S. C., & Haddad, M. D. C. F. L. (2019) · Ciência & Saúde Coletiva · doi:10.1590/1413-81232018243.02022017 · Cited by 155
The “A to Z” of Managing Type 2 Diabetes in Culturally Diverse Populations
Caballero, A. E. (2018) · Frontiers in Endocrinology · doi:10.3389/fendo.2018.00479 · Cited by 81
Leonard, C. E., Han, X., Brensinger, C. M., Bilker, W. B., Cardillo, S., Flory, J., & Hennessy, S. (2017) · Pharmacoepidemiology and Drug Safety · doi:10.1002/pds.4337 · Cited by 78
“Follow‐up began on cohort entry and continued until the first occurrence of the following: (1) death, as ascertained from linkage to the Social Security Administration Death Master File; (2) the 181st day; (3) >15 day gap in treatment with the study drug defining cohort entry; (4) a prescription for any other antidiab…”
BackgroundMethodInfluentialPrevalence and Impact of Unknown Diabetes in the ICU
Carpenter, D. L., Gregg, S. R., Xu, K., Buchman, T. G., & Coopersmith, C. M. (2015) · Critical Care Medicine · doi:10.1097/ccm.0000000000001353 · Cited by 69
Comprehensive efforts to increase adherence to statin therapy
Vonbank, A., Agewall, S., Kjeldsen, K. P., Lewis, B. S., Torp-Pedersen, C. T., Ceconi, C., Funck‐Brentano, C., Kaski, J. C., Niessner, A., Tamargo, J. L., et al. (2017) · European Heart Journal · doi:10.1093/eurheartj/ehw628 · Cited by 75
“(6, 21-24) A summary of published data on lipid goal attainment is provided in table 3.”
BackgroundLeykum, L. K., Lanham, H. J., Pugh, J. A., Parchman, M., Anderson, R. A., Crabtree, B. F., Nutting, P. A., Miller, W. L., Stange, K. C., & McDaniel, R. R. (2014) · Implementation Science · doi:10.1186/s13012-014-0165-1 · Cited by 70
Gori, M., Gupta, D. K., Claggett, B. L., Selvin, E., Folsom, A. R., Matsushita, K., Bello, N. A., Cheng, S. C., Shah, A. M., Skali, H., et al. (2016) · Diabetes Care · doi:10.2337/dc15-1760 · Cited by 71
Bukhsh, A., Khan, T. M., Lee, S. W. H., Lee, L., Chan, K., & Goh, B. H. (2018) · Frontiers in Pharmacology · doi:10.3389/fphar.2018.00339 · Cited by 73
Aroda, V. R., González-Galvez, G., Grøn, R., Halladin, N., Haluzík, M., Jermendy, G., Kok, A., Őrsy, P., Sabbah, M., Sesti, G., et al. (2019) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(19)30184-6 · Cited by 68
Calcium signalling and ER stress in insulin resistance and atherosclerosis
Özcan, L., & Tabas, I. A. (2016) · Journal of Internal Medicine · doi:10.1111/joim.12562 · Cited by 74
Burrows, N. R., Li, Y., Gregg, E. W., & Geiss, L. S. (2017) · Diabetes Care · doi:10.2337/dc17-1259 · Cited by 72
Self-citationDistinct HbA1c trajectories in a type 2 diabetes cohort
Walraven, I., Mast, M. R., Hoekstra, T., Jansen, A. P. D., van der Heijden, A. A. W. A., Rauh, S. P., Rutters, F., Riet, E. V. ‘., Elders, P. J. M., Moll, A. C., et al. (2014) · Acta Diabetologica · doi:10.1007/s00592-014-0633-8 · Cited by 69
“This proportion is higher than that resulting from a recent observational study from the USA [18], in which almost half of the U.”
ResultDu, Y., Heidemann, C., Rosario, A. S., Buttery, A. K., Paprott, R., Neuhauser, H. K., Riedel, T., Icks, A., & Scheidt‐Nave, C. (2015) · BMJ Open Diabetes Research & Care · doi:10.1136/bmjdrc-2015-000135 · Cited by 107
“Results from these studies have consistently demonstrated significant improvements in the control of HbA1c, BP, and lipids among adults with diabetes, although absolute changes over the past decade were generally smaller than those observed in the present study.(21) 34–37 Between the 1999–2002 and 2007–2010 NHANES sur…”
ResultInfluentialA Multiethnic Study of Pre-Diabetes and Diabetes in LMIC
Shen, J., Kondal, D., Rubinstein, A., Irazola, V. E., Gutiérrez, L., Miranda, J. J., Bernabé‐Ortiz, A., Lazo-Porras, M., Levitt, N. S., Steyn, K., et al. (2016) · Global Heart · doi:10.1016/j.gheart.2015.12.015 · Cited by 76
Self-citationCanagliflozin Prevents Diabetes-Induced Vascular Dysfunction in ApoE-Deficient Mice
Rahadian, A., Fukuda, D., Salim, H. M., Yagi, S., Kusunose, K., Yamada, H., Soeki, T., & Sata, M. (2020) · Journal of Atherosclerosis and Thrombosis · doi:10.5551/jat.52100 · Cited by 63
Overview of Therapeutic Inertia in Diabetes: Prevalence, Causes, and Consequences
Karam, S., Dendy, J. A., Polu, S., & Blonde, L. (2020) · Diabetes Spectrum · doi:10.2337/ds19-0029 · Cited by 72
Crowley, M. J., Edelman, D., McAndrew, A. T., Kistler, S., Danus, S., Webb, J. A., Zanga, J., Sanders, L. L., Coffman, C. J., Jackson, G. L., et al. (2016) · Telemedicine and e-Health · doi:10.1089/tmj.2015.0145 · Cited by 68
“0%—approximately 13% of diabetes patients—are at particularly high risk for complications and costs.(4) Because improved control can reduce diabetes complications,(5) patients with persistent poorly controlled diabetes mellitus (PPDM), or maintenance of an HbA1c >9.”
Clinical Outcomes of Metabolic Surgery: Microvascular and Macrovascular Complications
Adams, T. D., Arterburn, D. E., Nathan, D. M., & Eckel, R. H. (2016) · Diabetes Care · doi:10.2337/dc16-0157 · Cited by 64
“While the incidence of diabetes has increased worldwide, this careful review of nonsurgical diabetes diagnosis and treatment concludes that efforts to reduce risk factors are increasing (65), whereas overall renal disease and CVD occurring among the population with diabetes “have been reduced substantially in the past…”
BackgroundMetabolic Surgery for Type 2 Diabetes: Changing the Landscape of Diabetes Care
Cefalu, W. T., Rubino, F., & Cummings, D. E. (2016) · Diabetes Care · doi:10.2337/dc16-0686 · Cited by 65
Outpatient diabetes clinical decision support: current status and future directions
O'Connor, P. J., Sperl‐Hillen, J. M., Fazio, C. J., Averbeck, B. M., Rank, B. H., & Margolis, K. L. (2016) · Diabetic Medicine · doi:10.1111/dme.13090 · Cited by 63
Shivashankar, R., Kirk, K., Kim, W. C., Rouse, C., Tandon, N., Venkat Narayan, K. M., & Ali, M. K. (2015) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2014.11.004 · Cited by 52
Self-citationUric Acid and Diabetic Nephropathy Risk
Mauer, M. S., & Doria, A. (2018) · Contributions to nephrology · doi:10.1159/000484284 · Cited by 70
McLendon, S. F., Wood, F. G., & Stanley, N. M. (2019) · Public Health Nursing · doi:10.1111/phn.12601 · Cited by 63
Sheon, A. R., Bolen, S. D., Callahan, B., Shick, S., & Perzynski, A. T. (2017) · JMIR Diabetes · doi:10.2196/diabetes.6751 · Cited by 62
“Medication, diet, and physical activity can limit the health consequences of T2D [2,3], but recommended targets for blood sugar, lipids, and blood pressure control are met by only about one-half of those affected [4].”
BackgroundZhu, Y.-Y., Cong, W., Shen, L., Wei, H., Wang, Y., Wang, L., Ruan, K., Wu, F. L., & Feng, Y. (2013) · Molecular BioSystems · doi:10.1039/c3mb70392d · Cited by 65
Aguiar, P. M., da Silva, C. H. P., Chiann, C., Dórea, E. L., de Lyra, D. P., & Storpirtis, S. (2016) · Journal of Evaluation in Clinical Practice · doi:10.1111/jep.12606 · Cited by 69
“First, it is essential to note that the high glycemic-control rate observed in the recruitment of patients contrasts with national and international findings [3,34].”
ResultGlycemic control in type 2 diabetes: from medication nonadherence to residual vascular risk
Giugliano, D., Maiorino, M. I., Bellastella, G., & Esposito, K. (2018) · Endocrine · doi:10.1007/s12020-017-1517-9 · Cited by 63
Bukhsh, A., Khan, T. M., Nawaz, M. S., Sajjad, H., Chan, K., Lee, L., & Goh, B. H. (2018) · Patient Preference and Adherence · doi:10.2147/ppa.s177314 · Cited by 61
Jeon, J. Y., Kim, D. J., Ko, S., Kwon, H., Lim, S. K., Choi, S. H., Kim, C. S., An, J. H., Kim, N. H., Won, J. C., et al. (2014) · Diabetes & Metabolism Journal · doi:10.4093/dmj.2014.38.3.197 · Cited by 61
“With respect to the overall glycemic control, 45.6% reached the target of 7.0% HbA1c, according to the American Diabetes Association standard, whereas 27% reached the target when the standard was set to 6.5% HbA1c, according to the International Diabetes Federation and KDA standard (Fig.”
BackgroundInfluentialTrends in the prevalence and management of diabetes in Korea: 2007-2017
Shin, J.-Y. (2019) · Epidemiology and Health · doi:10.4178/epih.e2019029 · Cited by 62
“6% between 2003-2006 and 2007-2010 [31].”
Trends in cancer mortality among people with vs without diabetes in the USA, 1988–2015
Harding, J. L., Andes, L. J., Gregg, E. W., Cheng, Y. J., Weir, H. K., Bullard, K. M., Burrows, N. R., & Imperatore, G. (2019) · Diabetologia · doi:10.1007/s00125-019-04991-x · Cited by 65
Self-citationYang, C., Su, P.-F., Hung, J.-Y., Ou, H., & Kuo, S. (2020) · Cardiovascular Diabetology · doi:10.1186/s12933-020-01082-9 · Cited by 63
“This HbA1c cut-off point was considered because it is clinically recognized as the optimal HbA1c level for middle-aged or elderly diabetes patients with complications [38, 39].”
BackgroundWan, E. Y. F., Fung, C. S. C., Yu, E. Y. T., Chin, W. Y., Fong, D., Chan, A. K. C., & Lam, C. L. K. (2017) · Journal of the American Heart Association · doi:10.1161/jaha.117.006400 · Cited by 67
Excess diabetes mellitus-related deaths during the COVID-19 pandemic in the United States
Lv, F., Gao, X., Huang, A. H., Zu, J., He, X., Sun, X., Liu, J., Gao, N., Jiao, Y., Keane, M. G., et al. (2022) · EClinicalMedicine · doi:10.1016/j.eclinm.2022.101671 · Cited by 66
Trends in Diabetes Management Among US Adults: 1999–2016
Fang, M. (2020) · Journal of General Internal Medicine · doi:10.1007/s11606-019-05587-2 · Cited by 61
“8 percentage points, respectively, from 1999 to 2010.(8) There were, however, two exceptions.”
Wang, J., Geiss, L. S., Williams, D. E., & Gregg, E. W. (2015) · PLOS ONE · doi:10.1371/journal.pone.0134917 · Cited by 57
Self-citationPeyrot, M. F., Egede, L. E., Campos, C., Cannon, A. J., Funnell, M. M., Hsu, W. C., Ruggiero, L., Siminerio, L. M., & Stuckey, H. L. (2014) · Current Medical Research and Opinion · doi:10.1185/03007995.2014.947023 · Cited by 60
“, mediators were entered after the variables whose relationships with the outcomes they were hypothesized to mediate): (1) design, disease, demographic, and socioeconomic factors; (2) health status; (3) healthcare access/utilization; (4) subjective burden of diabetes; and (5) social support/ burden.”
BackgroundMethodInfluentialChawla, G., & Chaudhary, K. K. (2019) · Diabetes & Metabolic Syndrome Clinical Research & Reviews · doi:10.1016/j.dsx.2019.04.035 · Cited by 69
Diabetes-Related Mortality Among American Indians and Alaska Natives, 1990–2009
Cho, P., Geiss, L. S., Burrows, N. R., Roberts, D. L., Bullock, A. K., & Toedt, M. E. (2014) · American Journal of Public Health · doi:10.2105/ajph.2014.301968 · Cited by 58
Yokoyama, H., Araki, S., Kawai, K., Yamazaki, K., Tomonaga, O., Shirabe, S., & Maegawa, H. (2018) · BMJ Open Diabetes Research & Care · doi:10.1136/bmjdrc-2018-000521 · Cited by 61
“The increase in BMI values and obesity was observed in our study and in other studies.(14) 17 39 This is important because obesity causes higher medical expenditure and poorer controls for blood glucose, BP, and lipid, and recently steatohepatitis is becoming a topic in such patients leading to liver cirrhosis, CVD, a…”
Result
Metadata
- Authors
- Ali, M. K., Bullard, K. M., Saaddine, J. B., Cowie, C. C., Imperatore, G., & Gregg, E. W.
- Affiliations
- Centers for Disease Control and Prevention (US)
- National Institutes of Health (US)
- ORCID
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 2013-04-25
- Volume
- 368
- Issue
- 17
- Pages
- 1613-1624
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- OpenAlex
- W2124234371
- Cited by
- 979
- References
- 40
- Citations by year
- 2026: 19 · 2025: 23 · 2024: 31 · 2023: 45 · 2022: 57 · 2021: 61 · 2020: 77 · 2019: 106 · 2018: 98 · 2017: 112 · 2016: 106 · 2015: 112 · 2014: 97 · 2013: 33
- FWCI
- 91.24
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- New England Journal of Medicine (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Education
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
- Keywords
- diabetes management, glycemic control, HbA1c, blood pressure control, LDL cholesterol, tobacco use, coronary heart disease risk, preventive medicine, annual eye examination, foot examination, influenza vaccination, pneumococcal vaccination, self-monitoring of blood glucose, health disparities, NHANES, Behavioral Risk Factor Surveillance System
- MeSH terms
- Adolescent, Adult, Aged, Diabetes Mellitus, Female, Health Promotion, Glycated Hemoglobin, Humans, Male, Middle Aged, Nutrition Surveys, Patient Compliance, Risk Factors, Socioeconomic Factors, United States, Body Mass Index, Outcome Assessment, Health Care, Age Distribution, Sex Distribution, Quality Indicators, Health Care, Young Adult
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.